A Phase II Study Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination with Carboplatin in Extensive Stage Small Cell Lung Cancer

IRB/UVA Tracking #
21719
Contact
Gracie Hockenberry
Contact Email
Contact Phone
1.434.297.7784
Phase
II
Primary purpose
Treatment
Cancer PI
Ryan Gentzler
Status
OPEN TO ACCRUAL
Ages
Adult